Position in ABT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$226,003,395
+$144,800,050 QoQ
Shares Held
2,490,670
+214.9% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#75
of 2,959 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $1,100,565,386 across 14 Medical Devices names. ABT ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
3,139,285 | $283,979,721 | |
| 2 | ABT |
Abbott Laboratories
This page
|
2,490,670 | $226,003,395 | |
| 3 | GKOS |
GLAUKOS Corp
|
1,514,931 | $211,726,756 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
1,177,461 | $101,367,617 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
783,636 | $93,213,502 | |
| 6 | HAE |
Haemonetics Corp
|
550,195 | $41,264,625 | |
| 7 | PEN |
Penumbra Inc
|
128,012 | $40,419,789 | |
| 8 | BSX |
Boston Scientific Corp
|
806,732 | $34,431,321 |
All Filings in ABT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,003,395 | 2,490,670 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $81,203,345 | 790,916 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $105,669,586 | 843,400 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $44,870,623 | 396,699 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $98,307,402 | 862,270 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,357,352 | 407,635 | Shares | Sole | 2024-08-14 | |
| 2021-12-31 | $3,706,669 | 26,337 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,584,654 | 64,206 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $4,046,876 | 33,769 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||